Micro-rna for the regulation of cardiac apoptosis and contractile function
AssigneeMiragen Therapeutics, Inc.
InventorsStefanie DIMMELER, Reinier A. Boon, Ariane Fischer, Andreas M. Zeiher
Life of this patent
Estimating the term…
Abstract
The present invention relates to treating or preventing age-related cardiomyopathy by modulating the expression or activity of a miR-34 family member and/or PNUTS. Methods of treating or preventing age-related cardiomyopathy include administering an inhibitor of miR-34 expression or activity or an agonist of PNUTS expression or activity. Also provided herein are methods of treating or preventing cardiac fibrosis and myocardial infarction by administering an inhibitor of miR-34 expression or activity or an agonist of PNUTS expression or activity.
Claims15
A method of treating or preventing age-related cardiomyopathy, cardiac fibrosis, or myocardial infarction in a subject in need thereof comprising administering to the subject an inhibitor of a miR-34 family member.
Dependencies are inferred from the claim text.